ID   1.2B4
AC   CVCL_2258
DR   ECACC; 10070103
DR   Wikidata; Q54399845
RX   Patent=US20040005702;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3524.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Produced by electrofusion of HuP-T3 with a primary culture of human pancreatic islets.
CC   Doubling time: ~20 hours (ECACC=10070103).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (from parent cell line).
ST   Source(s): ECACC; Patent=US20040005702
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D18S51: 16,17
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 10,14
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1299 ! HuP-T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   Patent=US20040005702;
RA   Flatt P.R., McClenaghan N.H.;
RT   "Insulin producing cell-line.";
RL   Patent number US20040005702, 08-Jan-2004.
//